abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: what is presented is using the selective coagulation factor Xa inhibitor 5-chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophencarboxamide (rivaroxaban) for treating and/or prevention cardiac embarrassment. n EFFECT: possibility to treat and/or prevent cardiac embarrassment has been shown. n 2 cl, 1 tbl |